Learn More
Medchemexpress LLC LP-261 | 915412-67-8 | 99.9% | C22H19N3O4S | 50 MG

Supplier: Medchemexpress LLC HY1438950MG
LP-261 is a potent, orally active anti-mitotic agent that inhibits tubulin polymerization in vitro with an EC50 of 3.2 μM. It has shown the ability to inhibit the growth of human non-small-cell lung tumors (NCI-H522) in vivo and is used in cancer research.
- Potent and orally active anti-mitotic agent.
- Inhibits tubulin polymerization in vitro.
- Shows potent G2/M block activity in various cell lines (MCF-7, H522, Jurkat, SW-620, BXPC-3, and PC-3) with IC50 values ranging from 0.01 μM to 0.38 μM.
- Effectively inhibits tumor growth in a human non-small-cell lung tumor xenograft model in NCr-nu mice, with a 96% reduction in mean tumor volume at 50 mg/kg.
- Displays rapid oral adsorption with a Tmax of 2.0 hours in rats.
- Exhibits moderate elimination rate with a terminal half-life of 1.4 hours in rats.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.